"Wet Macular Degeneration" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of RETINAL DEGENERATION in which abnormal CHOROIDAL NEOVASCULARIZATION occurs under the RETINA and MACULA LUTEA, causing bleeding and leaking of fluid. This leads to bulging and or lifting of the macula and the distortion or destruction of central vision.
| Descriptor ID |
D057135
|
| MeSH Number(s) |
C11.768.585.439.622
|
| Concept/Terms |
Wet Macular Degeneration- Wet Macular Degeneration
- Degeneration, Wet Macular
- Degenerations, Wet Macular
- Macular Degeneration, Wet
- Macular Degenerations, Wet
- Wet Macular Degenerations
|
Below are MeSH descriptors whose meaning is more general than "Wet Macular Degeneration".
Below are MeSH descriptors whose meaning is more specific than "Wet Macular Degeneration".
This graph shows the total number of publications written about "Wet Macular Degeneration" by people in this website by year, and whether "Wet Macular Degeneration" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 2 | 1 | 3 |
| 2012 | 4 | 0 | 4 |
| 2013 | 3 | 2 | 5 |
| 2014 | 5 | 0 | 5 |
| 2015 | 9 | 0 | 9 |
| 2016 | 2 | 0 | 2 |
| 2017 | 2 | 0 | 2 |
| 2018 | 3 | 1 | 4 |
| 2019 | 9 | 0 | 9 |
| 2020 | 14 | 0 | 14 |
| 2021 | 4 | 0 | 4 |
| 2022 | 4 | 0 | 4 |
| 2023 | 5 | 0 | 5 |
| 2024 | 9 | 1 | 10 |
| 2025 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Wet Macular Degeneration" by people in Profiles.
-
Kalavar M, Sridhar J. Clinical trials and real-world studies examining faricimab and high-dose aflibercept for wet age-related macular degeneration and diabetic macular edema. Curr Opin Ophthalmol. 2025 May 01; 36(3):189-198.
-
Momenaei B, Yonekawa Y, Abril P, McCullough R, Abbey AM. Outcomes of Intravitreal Aflibercept 8 mg in Eyes With Neovascular Age-Related Macular Degeneration Previously Treated With Faricimab. Ophthalmic Surg Lasers Imaging Retina. 2025 Apr; 56(4):206-211.
-
Alshaikhsalama AM, Alsoudi AF, Wai KM, Koo E, Mruthyunjaya P, Rahimy E. Association between Obstructive Sleep Apnea and Age-related Macular Degeneration Development and Progression. Ophthalmol Retina. 2025 Jun; 9(6):537-545.
-
Alsoudi AF, Wai KM, Koo E, Mruthyunjaya P, Rahimy E. Curcuma-Based Nutritional Supplements and Risk of Age-Related Macular Degeneration. JAMA Ophthalmol. 2024 Dec 01; 142(12):1114-1121.
-
Kaufmann GT, Boucher N, Sharma C, Aggarwal N, Starr MR. Submacular Hemorrhage Rates Following Anti-Vascular Endothelial Growth Factor Injections for Exudative Age-Related Macular Degeneration. Am J Ophthalmol. 2025 Feb; 270:172-182.
-
Alsoudi AF, Koo E, Wai K, Mruthyunjaya P, Rahimy E. Ocular Neovascular Conversion and Systemic Bleeding Complications in Patients with Age-Related Macular Degeneration on Anticoagulants. Ophthalmology. 2025 Feb; 132(2):219-227.
-
Nanji K, Kennedy K, Fung M, Xie J, Hatamnejad A, Garg SJ, Wykoff CC, Chaudhary V. Impact of COVID-19 on a real-world treat-and-extend regimen with aflibercept for neovascular age-related macular degeneration. Can J Ophthalmol. 2025 02; 60(1):e92-e99.
-
Shaheen A, Ashkenazy N, Magraner M, Patel NA, Fortun J, Rosenfeld PJ, Schwartz SG, Haddock LJ, Dubovy SR, Sridhar J, Yehoshua Z, Kovach JL, Townsend JH, Smiddy WE, Flynn HW, Yannuzzi NA. Faricimab in Previously Treated Eyes With Neovascular Age-Related Macular Degeneration: An Assessment of Durability and Treatment Outcomes. Ophthalmic Surg Lasers Imaging Retina. 2024 09; 55(9):504-509.
-
Campochiaro PA, Avery R, Brown DM, Heier JS, Ho AC, Huddleston SM, Jaffe GJ, Khanani AM, Pakola S, Pieramici DJ, Wykoff CC, Van Everen S. Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study. Lancet. 2024 04 20; 403(10436):1563-1573.
-
Lee AY, Kovacs K, Orlin A, Kiss S, D'Amico DJ, Segal KL, Lelli GJ, Godfrey KJ. Incidence of Blepharoptosis Following Intravitreal Anti-Vascular Endothelial Growth Factor Injections. Am J Ophthalmol. 2024 Sep; 265:236-240.